News

IMG GmbH was certified by the Tübingen Regional Council in accordance with Article 111 of Directive 2001/83/EC and acquired a GDP certificate under the number DE_BW_05_GDP_2024_0005 on May 23, 2024.

*       *       *

IMG GmbH has expanded its range of available medicines and added a new drug, Methoxsalen G.L.Ph. 20 µg/ml, pack size 50 ampoules, aktive ingredient 8-Methoxypsoralen, for the treatment of oncological diseases using the photopheresis (also extracorporeal photopheresis, ECP) procedure.

*       *       *

IMG GmbH has expanded its wholesale license and additionally received permission to trade in medicinal products derived from blood and immunological medicinal products, as well as to store and transport medicinal products in the temperature range of +2 °C to +8 °C.

*       *       *

IMG GmbH has expanded its range of offered medicinal products and has added the following new medicinal product to its portfolio:

• EZMEKLY 1 mg hard capsules, pack size 42 tablets
• EZMEKLY 2 mg hard capsules, pack size 42 tablets
• EZMEKLY 1 mg tablets for the preparation of a suspension, pack size 42 tablets

Active substance: Mirdametinib, for the treatment of neurofibromatosis type 1 (NF1).